Press Releases
September 26, 2023
Panbela Announces Issuance of New Patent in China for Claims of a Novel Process for the Production of SBP-101
September 19, 2023
Panbela to Present at the LD Micro Investor Conference
September 5, 2023
Panbela Announces Issuance of New Patent in Chile for Claims of a Novel Process for the Production of Flynpovi
August 28, 2023
Panbela to Present at H.C. Wainwright 25th Annual Global Investment Conference
August 14, 2023
Panbela Announces Issuance of New Patent in Europe for Claims of a Novel Process for the Production of SBP-101
August 10, 2023
Panbela Provides Business Update and Reports Q2 2023 Financial Results
July 31, 2023
Panbela to Host 2nd Quarter 2023 Earnings Conference Call on 8/10/23
July 24, 2023
Panbela Opens Enrollment in UK and Germany for Aspire Trial in Pancreatic Cancer
All Countries/Regions in the Aspire Trial are Now Open and Actively Enrolling
Interim Data Analysis anticipated in Early 2024
July 19, 2023
Panbela Therapeutics to Receive a Total Up to $9.5 Million for Divestiture of Assets within Eflornithine (DFMO) Pediatric Neuroblastoma Program to US WorldMeds
July 10, 2023
Panbela Announces Preliminary Safety Analysis for ASPIRE Trial
Events & Presentations